A sperm forward motility–stimulating protein was purified from goat serum and characterized. The research provides a potential nonsteroidal biomolecule and its antibody that may solve some global reproductive problems.
Vitrification does not significantly affect the methylation patterns of the CpG islands in the Dnmt1o, Hat1, and Hdac1 promoters in mouse metaphase II oocytes, but reduces expression of Dnmt1o mRNA.
Human ovarian follicles express resistin, which decreases insulin-like growth factor I (IGF-I)-induced steroid production, P450scc and P450 aromatase protein levels, and IGF-I receptor signaling pathways in primary human granulosa cells.
Mitochondria are significantly activated in growthrestricted fetuses, which may be a response to adverse intrauterine environments rather than to genetic factors.
Inhibition of lipopolysaccharide-induced RANTES production by estrogen receptor b agonist diarylpropionitrile in the macrophage cell line RAW264.7 may be mediated via repression of nuclear factor kB activation.
Diabetes induces oxidative DNA damage in the corpus cavernosum. Angiotensin-(1–7), a counter-regulator of angiotensin II signaling, significantly attenuates DNA damage and structural changes in the corpus cavernosum.
In subfertile women with anovulation we evaluated the prevalence of additional fertility-reducing factors and the diagnostic and prognostic capacity of fertility tests.
Caucasian and Asian women with polycystic ovary syndrome living in the same geographic region have a similar prevalence of hirsutism and other markers for androgen excess.
Below the age of 40, women with polycystic ovary syndrome have higher clinical pregnancy and live-birth rates after in vitro fertilization compared with women with tubal factor infertility. After 40, despite a higher oocyte yield, there is no difference in pregnancy outcomes.
Functional magnetic resonance imaging of limbic activation with emotional processing differed between healthy women and women with insulinresistant polycystic ovary syndrome.
There is increasing awareness of the importance of endometrial development in infertile patients. In a large unexplained infertility population, we describe the factors affecting adverse endometrial development during IUI cycles.
Several factors, such as genetic, epigenetic, steroids, growth factors, cytokines, chemokines, and extracellular matrix components, have been identified in myometrial and leiomyoma biology that are hereby reviewed and discussed.
Clinical-grade vitrification of human ovarian tissue in fertility preservation, with the use of only one permeating cryoprotectant, ethylene glycol, in a closed system results in intact follicular ultrastructure.
Several phthalates but not bisphenol A were associated with incident endometriosis in the population cohort, whereas two phthalates emerged in sensitivity analyses for the operative cohort
In this systematic meta-analysis of both cohort and case-control studies, published through September 2012, we found an increased risk for cancer among children born after fertility treatment.
Among twin pregnancies, maternal chronic disease was associated with additional risk of earlier delivery and cesarean section after spontaneous labor, but not with other obstetric complications.
Leptin and its receptor (ObR) are induced in ovarian endometriomas. There was positive correlation between ObR and adiponectin expression. The leptin-ObR system was associated with adiponectin gene expression in endometriotic cells.
Overexpression of matrix metalloproteinases (MMPs) 2 and 9 and decrease in tissue inhibitor of MMP (TIMP) 1 were associated with poor IVF outcome in women with endometriosis. Progesterone supplementation following IVF improved the MMP-9/TIMP-1 imbalance significantly in these women.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.